Page results
-
This two-part workshop is specially created for teenagers seeking to understand their anxiety more deeply and discover practical, effective strategies to manage it.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.
-
The National Hospital for Neurosurgery at Cleveland Street opened its doors to patients on 4 April 2016. This brand new centre was developed to provide a new home for our Pain Management Centre, a nationally recognized centre of excellence for people with longstanding pain. Set over two floors the centre has group rooms and consulting clinic rooms as well as procedure rooms.Some multiple sclerosis clinics and outpatient appointments for the National Prion Clinic are also held at the centre.
-
The High Court has today (26 March) ruled that parents can consent on behalf of their child for hormone-blocking treatment in cases of gender dysphoria.
-
The National Hospital for Neurology and Neurosurgery (NHNN), Queen Square, is the UK's largest dedicated neurological and neurosurgical hospital. It provides comprehensive services for the diagnosis, treatment and care of all conditions that affect the brain, spinal cord, peripheral nervous system and muscles. Services include specialist neurosurgery, a brain tumour unit, the Hyper-acute Stroke Unit (HASU), an acute brain injury unit, the National Prion Clinic, a pioneering neuro-rehabilitation unit, the UK's first interventional MRI scanner, the largest specialised neurosurgical ITU and the only neuromedical ITU in the country. Together with its neighbour, the UCL Queen Square Institute of Neurology, it is a major international centre for research and training.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
The Royal London Hospital for Integrated Medicine (RLHIM) is a centre for evidence-based practice, education and research, specialising in chronic and complex medical conditions. Our mission is to provide a person-centred, holistic approach, including self-care, in order to help people with chronic and complex medical conditions live well and feel better. Our approach considers the whole person and their environment in the quest for optimal health and wellbeing. In order to achieve this, we provide a combination of lifestyle strategies, medical, physical and psychological treatment, as well as advice on safe and appropriate use of complementary therapies. We also deliver and encourage self-care approaches which can continue to be used by patients after discharge. All RLHIM services are outpatient-based and are staffed by experienced healthcare professionals.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
“Vaccines do not kill, the virus does”: that was the message from local leaders from a variety of different faiths during an event at the newly opened vaccination centre at the Business Design Centre in Islington.
File results
-
FOI/2023/0729 - In-patient beds and operating theatres
-
FOI/2023/0736 - Placements in locked rehabilitation for adults with mental health diagnosis
-
FOI/2023/0737 - Cancelled appointments at maternity unit from December 2022
-
FOI/2023/0738 - Patients treated with Biologic medicines in gastroenterology
-
FOI/2023/0741 - Anaesthesia Associates staff
-
FOI/2023/0742 - Cancer treatments
-
FOI/2023/0751 - Patient numbers and drug spend for Waldenstrom's Macroglobulinaemia
-
FOI/2023/0752 - Cancer patient deaths whilst on waiting list
-
FOI/2023/0753 - Drug-related admissions in A&E 2018-2023
-
FOI/2023/0756 - Physician Associates and Anaesthesia Associates staff